Awareness of gingival enlargement and pattern of dental care utilization amongst hypertensive patients in a Nigerian tertiary hospital

Main Article Content

Chioma Priscillia Mini
Grace Onyenashia Alade

Abstract

Background: Some antihypertensive drugs have been implicated in drug-induced gingival enlargement (DIGE), however, there is paucity in the literature on the level of awareness of DIGE among these patients. Hence, this study aims to assess the awareness, prevalence of DIGE, and the impact of dental care service (scaling and polishing) on the prevalence of DIGE among hypertensive patients at the University of Port Harcourt Teaching Hospital (UPTH).


Methodology: A cross-sectional study was conducted among hypertensive patients attending the Cardiology Outpatient Clinic at UPTH. Participants were selected using the convenience sampling method. Data collection was done using structured questionnaires, medical records and clinical oral examinations. Information on demographic variables, duration of antihypertensive medication use and dental care service utilization were also recorded. Data was analysed with significance set at p<0.05.


Results: There were one hundred and fifty (150) respondents; 64 males and 86 females, with an M: F of 1:1.25. The prevalence of gingival enlargement was 29.3%, with higher prevalence in patients on calcium channel blockers (Amlodipine) in combination with Angiotensin II receptor blocker (Telmisartan). None of the subjects was aware of gingival enlargement in hypertensive patients. Level of education, type of antihypertensive medications and no scaling & polishing were significantly associated with increased prevalence of gingival enlargement (p = 0.000).


Conclusion: The prevalence of drug-induced gingival enlargement among the participants was 29.3%, with grade I (interdental) gingival enlargement being more common and among subjects on long-term use of CCBs in combination with ARBs. All subjects were unaware of drug-induced gingival enlargement in hypertensive patients. There was a negative association between oral hygiene status and drug-induced gingival enlargement.

Downloads

Download data is not yet available.

Article Details

How to Cite
Awareness of gingival enlargement and pattern of dental care utilization amongst hypertensive patients in a Nigerian tertiary hospital. (2025). Port Harcourt Medical Journal, 19(3), 154-164. https://doi.org/10.60787/phmj.v19i3.214
Section
Original Articles
Author Biography

Grace Onyenashia Alade, Department of Community Dentistry and Periodontology, Faculty of Dentistry, College of Health Sciences, University of Port Harcourt, Rivers State, Nigeria.

Email: graceochos@yahoo.co.uk

Phone: +2348035039603

References

1. Naish J, Court DS. Medical sciences e-book, 2nd ed. Philadelphia, Elsevier Health Sciences, 2014; 562 -1474.

2. Bajkovec I, Mrzljak A, Likic R, Alajbeg I. Drug-induced gingival overgrowth in cardiovascular patients. World J Cardiol 2021;13(4):68-75.

3. Chandra KS, Ramesh G. The fourth-generation Calcium channel blocker: cilnidipine. Indian Heart J 2013;65(6):691-695..

4. Fardal Ø, Lygre H. Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed dedications, treatment responses and added treatment costs. J Clin Periodontol 2015;42(7):640-646.

5. Chouksey A, Awasthi N, Rai J, Chaudhary A. Association of drug-induced gingival enlargement (calcium channel blockers) and local factors: Who is the culprit? Int Dent Med J Adv Res 2017;3:1-4.

6. Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-induced gingival overgrowth--a review. Biol Pharm Bull 2005;28(10):1817-1821.

7. Kantarci A, Carranza FA, Hogan E. Gingival enlargement. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA, editors. Newman and Carranza’s Clinical Periodontology, 13th edition. Philadelphia: WB Saunders, 2018;1523-1572.

8. Claffey N. Plaque induced gingival diseases. In: Lindhe J, Lang NP, Karring T, editors. Clinical periodontology and implant dentistry, 4th edition. Oxford: Blackwell Munksgaard, 2003; 198-208.

9. Heasman PA, Hughes FJ. Drugs, medications and periodontal disease. Br Dent J 2014;217(8):411-419.

10. Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis. 2015;21(1):e51-61.

11. Doufexi A, Mina M, Ioannidou E. Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review. J Periodontol. 2005;76(1):3-10.

12. Dhale RP, Phadnaik MB. Conservative management of amlodipine influenced gingival enlargement. J Indian Soc Periodontol 2009;13(1):41-43.

13. Umeizudike KA, Olawuyi AB, Umeizudike TI, Olusegun-Joseph AD, Bello BT. Effect of calcium channel blockers on gingival tissues in hypertensive patients in Lagos, Nigeria: a pilot study. Contemp Clin Dent 2017; 8(4): 565-570.

14. Soroye MO, Sorunke ME. Gingival overgrowth and associated factors in a population of Nigerian hypertensives. World J Adv Res Rev 2021;12(03): 164–174.

15. Greene JC, Vermillion JR. The simplified oral hygiene index. J Am Dent Assoc 1964; 68:7-13.

16. Inglés E, Rossmann JA, Caffesse RG. New clinical index for drug-induced gingival overgrowth. Quintessence Int 1999;30(7):467-73..

17. Choi HM, Kim HC, Kang DR. Sex differences in hypertension prevalence and control: Analysis of the 2010-2014 Korea National Health and Nutrition Examination Survey. PLoS One. 2017;12(5):e0178334.

18. Rezaianzadeh A, Johari MG, Baeradeh N, Seif M, Hosseini SV. Sex differences in hypertension incidence and risk factors: a population-based cohort study in Southern Iran. BMC Public Health 2024;24(1):3575.

19. Chetrus V, Ion IR. Dental plaque – classification, formation, and identification. Int J Med Dent 2013;3(2):139–143.

20. Simanainen M. How an increase in income affects the use of dental care services among a low-income population: evidence from the Finnish basic income experiment. BMC Health Serv Res 2024;24(1):499.

21. Shah M, Shah V, Poojari ME, Bora N. Negligence of gingival overgrowth leading t o loss of entire dentition. J Indian Soc Periodontol 2024;28(4):494-498.

22. Fang L, Tan BC. Clinical presentation and management of drug-induced gingival overgrowth: a case series. World J Clin Cases 2021;9(32):9926-9934.

23. Lipsky MS, Su S, Crespo CJ, Hung M. Men and oral health: a review of sex and gender differences. Am J Mens Health 2021;15(3):15579883211016361

24. Bernabé E, Masood M, Vujicic M. The impact of out-of-pocket payments for dental care on household finances in low and middle income countries. BMC Public Health 2017;17(1): 109.

25. Chen L, Hong J, Xiong D, Zhang L, Li Y, Huang S, et al. Are parents’ education levels associated with either their oral health knowledge or their children’s oral health behaviors? A survey of 8446 families in Wuhan. BMC Oral Health 2020;20(1):203.

26. Buskin SA. The plaque control index: a practical method of assessing the effectiveness of oral hygiene procedures. J Dent Assoc S Afr 1977;32:397–399.

Similar Articles

You may also start an advanced similarity search for this article.